Detalles de la búsqueda
1.
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review.
Eur J Haematol
; 111(3): 491-498, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37382045
2.
Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer.
Curr Issues Mol Biol
; 44(11): 5756-5767, 2022 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36421674
3.
Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era.
J Immunother Precis Oncol
; 6(3): 150-157, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37637236
4.
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy.
Explor Target Antitumor Ther
; 4(3): 396-405, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37455826
5.
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival.
Cancers (Basel)
; 15(20)2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894419
6.
Oncolytic Viruses as an Adjunct to Immune Checkpoint Inhibition.
Front Biosci (Landmark Ed)
; 27(5): 151, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35638418
7.
Immunoglobin A Deficiency and Squamous Cell Carcinoma With a Rare Presentation as Anal Cancer.
J Med Cases
; 13(1): 26-30, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35211232
Resultados
1 -
7
de 7
1
Próxima >
>>